Practice Management News

Healio.com/Hepatology will offer live coverage from The Liver Meeting beginning Saturday.

The FDA has approved changes to the Olysio label reflecting that it can be used in combination with Sovaldi to treat patients with chronic hepatitis C virus genotype 1 infection, according to a media alert from the FDA.

A majority of treatment-naive and previously treated Japanese patients with hepatitis C virus genotype 2a infection achieved a sustained virologic response at 12 weeks after therapy with sofosbuvir and ribavirin, according to study results.

Setting out to become a researcher while mid-career as a clinical physician was a challenging prospect, but Colleen M. Fitzgerald, MD, MS, associate professor in the department of obstetrics and gynecology at Loyola University Chicago Medical Center, told HemOnc Today that anyone can do it if they set their mind to it.

Healio.com/Hepatology has compiled a list of the latest, most relevant research on hepatitis C virus infection, nonalcoholic fatty liver disease, drug-induced liver injury and more liver-related topics, presented recently at the ACG Annual Scientific Meeting in Philadelphia.

Chemotherapy, transarterial chemoembolization and successful biliary drainage were effective in improving overall survival among patients with unresectable hepatocellular carcinoma with obstructive jaundice, researchers from Korea found.

PHILADELPHIA — Gastric electric stimulation reduced symptoms in patients with refractory gastroparesis, according to data presented at the ACG Annual Scientific Meeting.

The summer stock market doldrums have morphed into a high octane volatile zig-zag. So I ask you – what is new? Haven’t we been here before? The trouble is that we just haven’t had a serious market correction since July-August 2011 and many moons before that. We have forgotten that markets go down and up, but deep in the recesses of our minds, we remember the pain of the deep market decline of 2008-2009. That is why recent headlines have scared us.

Hospital-owned physician groups, often aggregated in order to provide coordinated care, had higher costs per patient than physician-owned organizations, according to study results.

The Institute of Medicine elected 70 new members during its annual meeting on Oct. 20.